Medifast
MED
279 hedge funds and large institutions have $1.05B invested in Medifast in 2022 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 91 reducing their positions, and 30 closing their positions.
57% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 30
6% more funds holding
Funds holding: 264 → 279 (+15)
10% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 91
1% more capital invested
Capital invested by funds: $1.03B → $1.05B (+$13.2M)
0.39% less ownership
Funds ownership: 86.41% → 86.02% (-0.39%)
9% less call options, than puts
Call options by funds: $10.8M | Put options by funds: $11.9M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$7.87M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.95M |
| 4 |
JP Morgan Chase
New York
|
+$3.71M |
| 5 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$3.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$17.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$12.1M |
| 3 |
CCM
Chimera Capital Management
New York
|
-$9.6M |
| 4 |
Renaissance Technologies
New York
|
-$6.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.4M |
MED Hedge Fund Activity: Q4 2022 in Review
279 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2022, worth a combined $1.05B — up 1.3% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new MED positions and 30 closed out — a net gain of 17 holders — while 100 added to existing stakes and 91 trimmed.
The largest buyer was Vanguard Group, adding an estimated $11.4M. The largest seller was BlackRock, cutting an estimated $17.7M.
- 279 institutional investors held Medifast (MED) as of Q4 2022, up from 264 in Q3 2022.
- Funds reported $1.05B of Medifast stock for Q4 2022, up 1.3% quarter-over-quarter.
- 47 funds opened new Medifast positions in Q4 2022 and 30 closed out, a net change of +17 holders.
- The largest Medifast buyer in Q4 2022 was Vanguard Group, an estimated $11.4M added.
- The largest Medifast seller in Q4 2022 was BlackRock, an estimated $17.7M sold.
Based on aggregated 13F filings for Q4 2022.